SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/264D14CD88EDDC31A8D0AD0E1D356CF9E2ACC937F4C06F06B02C7DA01EBA71BF8EC5DD2A916E01BA376B5F6CFC1807F8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/264D14CD88EDDC31A8D0AD0E1D356CF9E2ACC937F4C06F06B02C7DA01EBA71BF8EC5DD2A916E01BA376B5F6CFC1807F8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/264D14CD88EDDC31A8D0AD0E1D356CF9E2ACC937F4C06F06B02C7DA01EBA71BF8EC5DD2A916E01BA376B5F6CFC1807F8
http://www.w3.org/2000/01/rdf-schema#comment
"there was no remarkable difference in any pharmacokinetic parameters of olmesartan between subjects with and without any major haplotypes in the three transporter genes we tested- SLCO1B1 SLCO1B3 and ABCC2"
xsd:string
http://purl.uniprot.org/uniprot/#_DC76C905D79083AE8B6F67148484850E475CDFE94B9AB16344575BF8E2E0F85F60CAB4721AB5B17448F973B452CC2662
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/264D14CD88EDDC31A8D0AD0E1D356CF9E2ACC937F4C06F06B02C7DA01EBA71BF8EC5DD2A916E01BA376B5F6CFC1807F8
http://purl.uniprot.org/uniprot/B3KP78
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/264D14CD88EDDC31A8D0AD0E1D356CF9E2ACC937F4C06F06B02C7DA01EBA71BF8EC5DD2A916E01BA376B5F6CFC1807F8
http://purl.uniprot.org/uniprot/#_B3KP78-mappedCitation-22695893
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/264D14CD88EDDC31A8D0AD0E1D356CF9E2ACC937F4C06F06B02C7DA01EBA71BF8EC5DD2A916E01BA376B5F6CFC1807F8